End of Alzheimer's? Scientists hail new dementia drug that slows disease by a third

3 May 2023, 23:33 | Updated: 4 May 2023, 06:23

Scientists have hailed a 'hugely significant' new drug
Scientists have hailed a 'hugely significant' new drug. Picture: Getty/Alamy

By Kit Heren

The world is “on the cusp of a first generation of treatments for Alzheimer’s disease”, experts have said, as a new drug was found to slow cognitive and functional decline.

Listen to this article

Loading audio...

The drug donanemab, made by Eli Lilly and Company, slowed decline by 35% to 36% in a late-stage phase 3 clinical trial, the company said.

Donanemab appeared to slow the decline associated with Alzheimer’s compared with placebo in 1,182 people with early-stage disease based on those with intermediate levels of a protein known as tau.

The drug also resulted in 40% less decline in the ability to perform activities of daily living, according to the firm.

Almost half (47%) of those on donanemab had no clinical progression of disease at one year compared with 29% on placebo (defined as no decline in the commonly-used Clinical Dementia Rating Scale Sum of Boxes score).

Scientists are 'excited' about the possibilities presented by the new drug for treating people with Alzheimers
Scientists are 'excited' about the possibilities presented by the new drug for treating people with Alzheimer's. Picture: Alamy

Furthermore, participants on donanemab experienced a 39% lower risk of progressing to the next stage of disease compared to placebo, according to Eli Lilly.

In those patients receiving donanemab, brain swelling, a known side effect of drugs of this type, occurred in 24% of the participants, with 6.1% experiencing symptoms.

Brain bleeding occurred in 31.4% of the donanemab group and 13.6% of the placebo group.Lilly said the incidence of serious brain swelling in the donanemab study was 1.6%, including two participants whose deaths were attributed to the condition and a third who died after an incident of serious brain swelling.

It said most cases of swelling or bleeds were “mild to moderate” and responded to treatment.

Some 850,000 people in the UK have Alzheimers
Some 850,000 people in the UK have Alzheimers. Picture: Getty

Daniel Skovronsky, Eli Lilly’s chief scientific and medical officer, said: "This is the first phase 3 trial of any investigational medicine for Alzheimer’s disease to deliver 35% slowing of clinical and functional decline."

Dr Richard Oakley, associate director of research at the Alzheimer’s Society in the UK, said: “After 20 years with no new Alzheimer’s drugs, we now have two potential new drugs in just 12 months – and for the first time, drugs that seem to slow the progression of disease. This could be the beginning of the end of Alzheimer’s disease.

“Based on today’s early results, donanemab appears to slow the progression of Alzheimer’s symptoms by 36% (as compared with 27% of last year’s breakthrough drug lecanemab).

"Promisingly, the trial also demonstrated a 40% slowing in decline of everyday activities such as driving, doing hobbies and managing finances.

"While we’ve seen lecanemab could slow progression by over seven months, we’ll need to see the full results to know if donanemab could do the same or even better."

Caller lost faith after wife died from Alzheimer's

Dr Susan Kolhaas, executive director of research and partnerships at Alzheimer’s Research UK, said: “This is incredibly encouraging, and another hugely significant moment for dementia research.

“A second drug for Alzheimer’s has been shown to slow people’s cognitive decline in a rigorous phase 3 trial. We’re now on the cusp of a first generation of treatments for Alzheimer’s disease, something that many thought impossible only a decade ago.

Read more: New Alzheimer's drug Lecanemab hailed as ‘historic’ but questions remain about side effects and impact of use

Read more: New Alzheimer's drug Lecanemab hailed as ‘historic’ but questions remain about side effects and impact of use

"The treatment effect is modest, as is the case for many first-generation drugs, and there are risks of serious side effects that need to be fully scrutinised before donanemab can be marketed and used.

"However, this news underlines the urgency of preparing the NHS to make these treatments available should regulators deem them safe and effective.

"People should be really encouraged by this news, which is yet more proof that research can take us ever closer towards a cure.”

More Latest News

See more More Latest News

Sgt Graham Saville, 46, who worked for Nottinghamshire Police, was fatally injured on the line in Balderton.

Cop uncle of Premier League star died after being hit by train while trying to save man on tracks

Experts have raised concerns after a new study found that 17 per cent of Brits admitted they don't bother washing their greens before eating them

Deadly bacteria found on popular salad leaves – experts warn Brits to rethink this common habit

Ian "H" Watkin from the "Steps" band.

Steps star says it is ‘mindblowing’ that Coachella forced his small Welsh festival to change its name

William Jonzi, 24, reportedly followed a paying customer through the international airport's e-gates and attempted to board the flight with no documents last Wednesday morning

Man wrestled off TUI flight at Gatwick after breaching security and boarding without documents

According to documents filed for the federal criminal case, officers found at least 14 unused Molotov cocktails in Soliman's possession when they arrested him.

Colorado firebomb attack was year in the making, FBI says, as suspect faces terror and hate crime charges

In the years leading up to the attack, Robert Price, 76, had been the target of a prolonged campaign of harassment and criminal damage, the Old Bailey was told.

Teenagers jailed for manslaughter after firework attack which killed widower in his own home

Cameron Norrie of Great Britain plays a forehand against Novak Djokovic of Serbia.

Cameron Norrie out of French Open after convincing defeat to Novak Djokovic

Exclusive
Lord George Robertson has warned the enemy is already at our door

'Our enemies are at our door', warns Lord Robertson as government unveils Strategic Defence Review

Households across the UK can claim up to £300 this June in payments to help with essential costs amid the cost of living crisis.

UK households to get £300 summer cost of living payment from this month

Britain's Jack Draper reacts as he plays against Kazakhstan's Alexander Bublik

Jack Draper knocked out of the French Open by Alexander Bublik

Holocaust survivor among victims in Colorado as man charged with murder after 'petrol bomb' attack at pro-Israel rally

Holocaust survivor among victims in Colorado as man charged with murder after 'petrol bomb' attack at pro-Israel rally

Jodey Whiting, 42, was found dead in 2017 just two weeks after her Employment Support Allowance (ESA) was cut.

Disabled mum-of-nine killed herself because her benefits were incorrectly cut, inquest finds

Arrivals at the UK Border at Heathrow Terminal 3

The UK airports that allow you to keep liquids in bags through security

AI, drones and missile defence investment part of UK new defence plans

Healey pledges to 'create British Army that is 10 times more lethal' as full details of defence review emerge

Rose West

Rose West has new grandchild after son welcomes baby with former model

Exclusive
The Prime Minister's promising a major overhaul of the UK's armed forces to defend against a new era of threat.

Britain’s war-fighting wake-up call: Defence review must be a start, not a slogan, warns military expert